Intersect ENT (XENT) Tops Q3 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. CMG
7. TENB
8. BIIB
9. KLAC
10. ETSY

Go back to Intersect ENT (XENT) Tops Q3 EPS by 3c

Intersect ENT Reports Third Quarter 2014 Results

November 5, 2014 4:01 PM EST

MENLO PARK, Calif., Nov. 5, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq: XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the third quarter of 2014.

Recent Accomplishments

Achieved Q3 revenue of $9.1 million, an increase of 113% over the third quarter of 2013.   Realized Q3 gross margin of 72% versus 66% in the third quarter of 2013.   Commenced enrollment in September of the PROGRESS study, a prospective, randomized, blinded, multi-center trial to assess the safety and efficacy of the... More